Wingate Wealth Advisors’s GE HealthCare GEHC Stock Holding History

Wingate Wealth Advisors’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-18	Closed	-$1.41K	–	215
2024 Q4	$1.41K	Buy	+18	New	+$1.53K	﹤0.01%	442

Other funds holding GEHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wingate Wealth Advisors's GEHC Position: Q1 2025 in Review

Wingate Wealth Advisors sold out of GE HealthCare (GEHC) in Q1 2025, closing a stake of 18 shares — an estimated $1.41K sold.

Wingate Wealth Advisors first reported a position in GEHC in Q4 2024 and held it in 1 quarter. The position peaked at $1.41K in Q4 2024. 1,373 funds tracked by Wall St. Rank hold GEHC as of Q1 2025.

Wingate Wealth Advisors reported no remaining GE HealthCare position as of Q1 2025 after selling out during the quarter.
Wingate Wealth Advisors sold 18 GE HealthCare shares in Q1 2025, an estimated $1.41K.
Wingate Wealth Advisors first reported a position in GE HealthCare in Q4 2024 and held it in 1 quarter.
Wingate Wealth Advisors's GE HealthCare position peaked at $1.41K in Q4 2024.
1,373 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2025.

Based on Wingate Wealth Advisors's 13F filing for Q1 2025, filed 24 Apr 2025.